CHILDS CURE GENETIC RESEARCH NON PROFIT CORPORATION (EIN 833715487) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2019

Legal Domicile

Principal Officer

Raisa Aronova

Phone

6505909726

Tax Period

2023-01-01 to 2023-12-31

CHILDS CURE GENETIC RESEARCH NON PROFIT CORPORATION, founded in 2019, is a small nonprofit in the Health Care sector that reported $117K in total revenue in fiscal year 2023. Revenue fell 54% from the prior year — a significant decline worth monitoring. Expenses of $162K exceeded revenue, resulting in a 38% operating deficit.

Mission

SPONSOR AND MANAGE PRE-CLINICAL RESEARCH AND DRUG DISCOVERY PROGRAMS. RAISE AWARENESS ABOUT GENETIC DISORDERS AFFECTING CHILDREN, LEAD AND SPONSOR THE RESEARCH AND TREATMENTS TO HELP CHILDREN IN NEED. ASSIST WITH FISCAL SPONSORSHIP AND FUNDRAISING FRAMEWORK TO HELP PARENTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $117,108

Program Service Revenue $0

Investment Income $45

Other Revenue $0

TOTAL REVENUE $117,153

Expense Breakdown

Grants Paid $160,563

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $160,563

Other Expenses $1,360

TOTAL EXPENSES $161,923

Year-over-Year Comparison

	2023	2022	Change
Revenue	$117,153	$253,620	-0.5%
Expenses	$161,923	$103,814	+0.6%
Net Income	$-44,770	$149,806	-1.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ILYA MUSAYEV	EXECUTIVE DIRECTOR	40	Officer	$0	$0	$0
RAISA ARONOVA	PRESIDENT	20	Officer	$0	$0	$0
VAMSI PRAKHYA	TREASURER	5	Officer	$0	$0	$0
JAINU JOGANI	SECRETARY	20		$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$117,153	$161,923	$812,083	$-44,770
2022	$253,620	$103,814	$856,853	$149,806
2021	$236,985	$70,048	$707,047	$166,937
2020	$302,301	$127,639	$537,101	$174,662

CHILDS CURE GENETIC RESEARCH NON PROFIT CORPORATION